Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

Antonella Cusimano(Institute for Biomedical Research and Innovation), Melchiorre Cervello(Foundation for Biomedical Research)

International Journal of Oncology

June 21, 2017

10.3892/ijo.2017.4049

Cited by 94

Related Papers

NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance

|Cell Death and Disease|2016|141

Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies

|Drug Delivery|2007|72

Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

|PLoS ONE|2013|50

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

|Cell Death and Disease|2018|47